BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer. 2010;54:176. [PMID: 19743301 DOI: 10.1002/pbc.22262] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Sciveres M, Marrone G, Pipitone S, Riva S, Spada M, Gridelli B, Maggiore G. Successful First-line Treatment With Propranolol of Multifocal Infantile Hepatic Hemangioma With High-flow Cardiac Overload. Journal of Pediatric Gastroenterology & Nutrition 2011;53:693-5. [DOI: 10.1097/mpg.0b013e3182201a4e] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Haider KM, Plager DA, Neely DE, Eikenberry J, Haggstrom A. Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J AAPOS 2010;14:251-6. [PMID: 20603059 DOI: 10.1016/j.jaapos.2010.05.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
3 De Corti F, Crivellaro C, Zanon GF, Luzzatto C. Consumptive hypothyroidism associated with parotid infantile hemangioma. J Pediatr Endocrinol Metab 2015;28:467-9. [PMID: 25153570 DOI: 10.1515/jpem-2013-0420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Grzesik P, Wu JK. Current perspectives on the optimal management of infantile hemangioma. Pediatric Health Med Ther 2017;8:107-16. [PMID: 29388636 DOI: 10.2147/PHMT.S115528] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Szychta P, Stewart K, Anderson W. Treatment of Infantile Hemangiomas with Propranolol: Clinical Guidelines. Plastic and Reconstructive Surgery 2014;133:852-62. [DOI: 10.1097/prs.0000000000000007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Frommelt P, Juern A, Siegel D, Holland K, Seefeldt M, Yu J, Uhing M, Wade K, Drolet B. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma. Pediatr Dermatol 2016;33:405-14. [DOI: 10.1111/pde.12869] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
7 Gnarra M, Behr G, Kitajewski A, Wu JK, Anupindi SA, Shawber CJ, Zavras N, Schizas D, Salakos C, Economopoulos KP. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr 2016; 5(3): 273-280 [PMID: 27610342 DOI: 10.5409/wjcp.v5.i3.273] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
8 Lakhoo K, Sowerbutts H. Neonatal tumours. Pediatr Surg Int 2010;26:1159-68. [DOI: 10.1007/s00383-010-2738-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
9 Raabe EH, Keefer JR, Mitchell SE, Hong K, DiFazio M, Strouse JJ. Subtotal splenic embolization is a safe and effective treatment for isolated splenic vascular tumors associated with consumptive coagulopathy. J Pediatr Hematol Oncol 2011;33:383-6. [PMID: 21606851 DOI: 10.1097/MPH.0b013e3182172515] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Rubinstein JC, Christison-lagay ER. Successful treatment of visceral infantile hemangioma of the omentum and mesentery with propranolol. Journal of Pediatric Surgery Case Reports 2014;2:302-4. [DOI: 10.1016/j.epsc.2014.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Campbell V, Beckett R, Abid N, Hoey S. Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine. J Clin Res Pediatr Endocrinol 2018;10:294-8. [PMID: 29537380 DOI: 10.4274/jcrpe.4865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
12 Mhanna A, Franklin WH, Mancini AJ. Hepatic Infantile Hemangiomas Treated with Oral Propranolol-A Case Series: Hepatic Infantile Hemangiomas. Pediatric Dermatology 2011;28:39-45. [DOI: 10.1111/j.1525-1470.2010.01355.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
13 Sarialioglu F, Erbay A, Demir S. Response of infantile hepatic hemangioma to propranolol resistant to high-dose methylprednisolone and interferon-α therapy. Pediatr Blood Cancer. 2010;55:1433-1434. [PMID: 20981697 DOI: 10.1002/pbc.22691] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
14 Fernandez-Pineda I, Cabello-Laureano R. Differential diagnosis and management of liver tumors in infants. World J Hepatol 2014; 6(7): 486-495 [PMID: 25068000 DOI: 10.4254/wjh.v6.i7.486] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
15 Restrepo R, Palani R, Cervantes LF, Duarte A, Amjad I, Altman NR. Hemangiomas revisited: the useful, the unusual and the new Part 2: endangering hemangiomas and treatment. Pediatr Radiol 2011;41:905-15. [DOI: 10.1007/s00247-011-2090-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
16 Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128-140. [PMID: 23266923 DOI: 10.1542/peds.2012-1691] [Cited by in Crossref: 304] [Cited by in F6Publishing: 219] [Article Influence: 30.4] [Reference Citation Analysis]
17 Lauren C, Garzon MC. Treatment of infantile hemangiomas. Pediatr Ann 2012;41:1-7. [PMID: 22881415 DOI: 10.3928/00904481-20120727-10] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Lou Y, Peng WJ, Cao Y, Cao DS, Xie J, Li HH. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol. 2014;78:44-57. [PMID: 24033819 DOI: 10.1111/bcp.12235] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
19 Ji Y, Chen S, Xiang B, Xu Z, Jiang X, Liu X, Wang Q, Lu G, Yang L. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep 2016;6:31744. [PMID: 27530723 DOI: 10.1038/srep31744] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
20 Avagyan S, Klein M, Kerkar N, Demattia A, Blei F, Lee S, Rosenberg HK, Arnon R. Propranolol as a first-line treatment for diffuse infantile hepatic hemangioendothelioma. J Pediatr Gastroenterol Nutr 2013;56:e17-20. [PMID: 22331019 DOI: 10.1097/MPG.0b013e31824e50b7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
21 Yeh I, Bruckner AL, Sanchez R, Jeng MR, Newell BD, Frieden IJ. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol. 2011;28:267-275. [PMID: 21517953 DOI: 10.1111/j.1525-1470.2011.01421.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
22 Maruani A, Piram M, Sirinelli D, Herbreteau D, Saliba E, Machet MC, Lorette G. Visceral and mucosal involvement in neonatal haemangiomatosis. J Eur Acad Dermatol Venereol 2012;26:1285-90. [PMID: 22044599 DOI: 10.1111/j.1468-3083.2011.04285.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Menezes MD, McCarter R, Greene EA, Bauman NM. Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial. Ann Otol Rhinol Laryngol 2011;120:686-95. [PMID: 22097156 DOI: 10.1177/000348941112001010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
24 Muthamilselvan S, Vinoth PN, Vilvanathan V, Ninan B, Amboiram P, Sai V, Anand V, Scott JX. Hepatic haemangioma of infancy: role of propranolol. Ann Trop Paediatr 2010;30:335-8. [PMID: 21118629 DOI: 10.1179/146532810X12858955921393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Thompson PA, Chintagumpala M. Renal and hepatic tumors in the neonatal period. Semin Fetal Neonatal Med. 2012;17:216-221. [PMID: 22595862 DOI: 10.1016/j.siny.2012.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
26 Hsu TC, Wang JD, Chen CH, Chang TK, Wang TM, Chou CM, Lin HK. Treatment with propranolol for infantile hemangioma in 13 Taiwanese newborns and young infants. Pediatr Neonatol 2012;53:125-32. [PMID: 22503260 DOI: 10.1016/j.pedneo.2012.01.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
27 Tal R, Dotan M, Lorber A. Approach to haemangiomatosis causing congestive heart failure. Acta Paediatr 2016;105:600-4. [DOI: 10.1111/apa.13359] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 Kwon EK, Seefeldt M, Drolet BA. Infantile hemangiomas: an update. Am J Clin Dermatol 2013;14:111-23. [PMID: 23338947 DOI: 10.1007/s40257-013-0008-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
29 Horii KA, Drolet BA, Frieden IJ, Baselga E, Chamlin SL, Haggstrom AN, Holland KE, Mancini AJ, Mccuaig CC, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Garzon MC; for the Hemangioma Investigator Group. Prospective Study of the Frequency of Hepatic Hemangiomas in Infants with Multiple Cutaneous Infantile Hemangiomas: Hepatic Hemangiomas in Infants with Multiple Hemangiomas. Pediatric Dermatology 2011;28:245-53. [DOI: 10.1111/j.1525-1470.2011.01420.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
30 Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, Ammour A, Broue P, Vial J, Ohanessian G, Léauté-Labrèze C, Labenne M, Vabres P. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr. 2010;157:340-342. [PMID: 20488455 DOI: 10.1016/j.jpeds.2010.04.003] [Cited by in Crossref: 102] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
31 Hsi Dickie B, Fishman SJ, Azizkhan RG. Hepatic vascular tumors. Semin Pediatr Surg. 2014;23:168-172. [PMID: 25241093 DOI: 10.1053/j.sempedsurg.2014.06.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
32 Mazereeuw-hautier J. Quoi de neuf en dermatologie pédiatrique ? Annales de Dermatologie et de Vénéréologie 2009;136:S426-35. [DOI: 10.1016/s0151-9638(09)73384-8] [Reference Citation Analysis]
33 Vercellino N, Romanini MV, Pelegrini M, Rimini A, Occella C, Dalmonte P. The use of propranolol for complicated infantile hemangiomas. Int J Dermatol 2013;52:1140-6. [PMID: 23829783 DOI: 10.1111/j.1365-4632.2012.05795.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
34 Franchi-abella S, Gorincour G, Avni F, Guibaud L, Chevret L, Pariente D; SFIPP-GRRIF (Société Francophone d’Imagerie Pédiatrique et Périnatale-Groupe de Recherche Radiopédiatrique en Imagerie Foetale). Hepatic haemangioma—prenatal imaging findings, complications and perinatal outcome in a case series. Pediatr Radiol 2012;42:298-307. [DOI: 10.1007/s00247-011-2214-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
35 Rodrigues A, Forno A, Costa E, Berenguer A, Pilar C, Loureiro R, Rufino D, Barros A, Teixeira F. Diffuse infantile hepatic haemangioma-how to manage an incidental but potentially lethal finding. Oxf Med Case Reports 2018;2018:omy054. [PMID: 30151220 DOI: 10.1093/omcr/omy054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Gunturi N, Ramgopal S, Balagopal S, Scott JX. Propranolol therapy for infantile hemangioma. Indian Pediatr 2013;50:307-13. [PMID: 23680605 DOI: 10.1007/s13312-013-0098-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
37 Makin E, Davenport M. Fetal and neonatal liver tumours. Early Human Development 2010;86:637-42. [DOI: 10.1016/j.earlhumdev.2010.08.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
38 Craiglow BG, Antaya RJ. Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches. Paediatr Drugs 2013;15:133-8. [PMID: 23456550 DOI: 10.1007/s40272-013-0008-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
39 Santecchia L, Valassina MFB, Maggiulli F, Spuntarelli G, De Vito R, Zama M. Early Surgical Excision of Giant Congenital Hemangiomas of the Scalp in Newborns: Clinical Indications and Reconstructive Aspects. J Cutan Med Surg 2013;17:106-13. [DOI: 10.2310/7750.2012.11113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
40 Chai Q, Chen WL, Huang ZQ, Zhang DM, Fan S, Wang L. Preliminary experiences in treating infantile hemangioma with propranolol. Ann Plast Surg 2014;72:169-72. [PMID: 21629056 DOI: 10.1097/SAP.0b013e31821ee3a5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Holmes W, Mishra A, Gorst C, Liew S. Propranolol as first-line treatment for rapidly proliferating Infantile Haemangiomas. Journal of Plastic, Reconstructive & Aesthetic Surgery 2011;64:445-51. [DOI: 10.1016/j.bjps.2010.07.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 6.5] [Reference Citation Analysis]
42 Ferrandiz L, Toledo-Pastrana T, Moreno-Ramirez D, Bardallo-Cruzado L, Perez-Bertolez S, Luna-Lagares S, Rios-Martin JJ. Diffuse neonatal hemangiomatosis with partial response to propranolol. Int J Dermatol. 2014;53:e247-e250. [PMID: 23834677 DOI: 10.1111/ijd.12155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
43 Sánchez-carpintero I, Ruiz-rodriguez R, López-gutiérrez J. Propranolol en hemangiomas infantiles: eficacia clínica, riesgos y recomendaciones. Actas Dermo-Sifiliográficas 2011;102:766-79. [DOI: 10.1016/j.ad.2011.05.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
44 Fernández-Pineda I, Bernabeu-Wittel J. [Hepatic hemangiomas]. Gastroenterol Hepatol 2010;33:473-4; author reply 474-5. [PMID: 20537429 DOI: 10.1016/j.gastrohep.2010.03.001] [Reference Citation Analysis]
45 Sana L, Betalli P, Bravi M, Stroppa P, Cheli M, Sonzogni A, Licini L, Agazzi R, Colledan M, Parolini F, Alberti D, D'Antiga L. Hepatic hemangioendothelioma of infancy: clinical features of a large cohort of patients and proposed management. Pediatr Surg Int 2021;37:791-7. [PMID: 33515109 DOI: 10.1007/s00383-021-04860-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Oksiuta M, Matuszczak E, Debek W, Dzienis-koronkiewicz E, Hermanowicz A. Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature. The Journal of Maternal-Fetal & Neonatal Medicine 2014;29:64-8. [DOI: 10.3109/14767058.2014.986650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
47 Zavras N, Dimopoulou A, Machairas N, Paspala A, Vaos G. Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 2020;179:1-8. [DOI: 10.1007/s00431-019-03504-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
48 Laranjo S, Costa G, Paramés F, Freitas I, Martins JD, Trigo C, Pinto FF. The role of propranolol in the treatment of infantile hemangioma. Rev Port Cardiol 2014;33:289-95. [PMID: 24906291 DOI: 10.1016/j.repc.2013.10.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]